US69012T3059
US69012T3059
Outlook Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.413.535 | -- | -- |
| Cost of Revenue | 1.356.330 | -- | -- |
| Gross Profit | 57.205 | -- | -- |
| 67.118.871 | 71.703.235 | 6.4% | |
| Operating Income | -67.061.666 | -71.703.235 | 6.5% |
| Pretax Income | -63.976.692 | -75.363.914 | 15.1% |
| Net Income Common Stockholders | -62.424.863 | -75.366.714 | 17.2% |
| -- | -- | -- | |
| -- | -- | -- |